France’s cannabidiol market has undergone notable shifts especially since December 30, 2021 when a decree limited how hemp flower‑derived extracts may be used, essentially prohibiting retail sales of flowering tops of hemp even if they carry negligible THC, following concerns raised by the Council of State. The regulatory agency ANSES (Ag ence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail) in 2025 proposed that cannabidiol be classified as a presumed reproductive toxicant, citing animal studies indicating impaired fertility and development, triggering public consultation via the European Chemicals Agency. Legal suppliers such as Buddha Farm’s and Nobilis Product manufacture items like oils, cosmetics and full spectrum extracts using authorised hemp varieties with THC levels under 0.3%. French cosmetic producer Laboratoires Boiron in September 2023 unveiled “CBD by Boiron” range employing encapsulation via niosomes to help preserve active molecules until released in the epidermis. Companies like FrenchFarm claim traceability from organic hemp plantings, third‑party analysis, and careful packaging (tamper proof caps, lot numbers) to comply with French and EU safety standards. Public perception studies by BMC Public Health reveal that some 69.2% of adults have heard of cannabidiol and about 10.1% have used it at least once, while under half of those who have heard of it believe it to be harmful highlighting uncertainty among consumers.

Epidyolex from GW Pharmaceuticals remains the only medical cannabidiol preparation authorised for epilepsy use in France. Cosmetic regulation under EU Regulation 1223/2009 is enforced, and cosmetic CBD products must avoid any health claims, novel food authorisation under EU Regulation 2015/2283 is still required for most ingestible formulations. According to the research report, "France Cannabidiol Market Research Report, 2030," published by Actual Market Research, the France Cannabidiol market is anticipated to grow at more than 16.65% CAGR from 2025 to 2030.In France many established brands are active in the cannabidiol sphere. Nobilis Product based in Doubs offers seed‑to‑bottle traceability and lab testing, Buddha Farm’s supplies oils, gummies and creams across specialist shops and online outlets, Laboratoires Boiron enters the scene with creams and joint/minute relief gels under its CBD line. Specialist boutiques, e‑shops, pharmacies and tobacconists are frequent distribution channels, internet retailers must ensure compliance with decree of December 2021, exclusion of flowering tops and restricted THC thresholds. Advertising is tightly controlled, health claims are frequently challenged by ANSES or customs authorities, Boiron and other firms emphasize wellness, skin comfort, anti‑inflammatory effects rather than cure or disease claims. Supply chain constraints include sourcing hemp from authorised cultivars (often from Lower‑Normandy and Occitanie) that comply with European Catalogue of hemp varieties and European Common Catalogue, testing laboratories in Brittany, Île‑de‑France and Nouvelle‑Aquitaine are heavily used for pesticide and solvent residue screening to meet safety requirements.

Consumer preferences seem to be leaning toward broad‑spectrum and isolate extracts for ingestible oils, while cosmetic users favour formulations with organic virgin hemp oil or cold‑pressed seed oil such as those used by Chanvria, with elegant packaging and sustainable materials. Innovations include encapsulated delivery (Boiron), nanoformulations in creams and lip balms by smaller labs, premium gummies and “full spectrum” gummies like FrenchFarm’s line. Regulatory delays remain for edible or supplement products waiting for ‘novel food’ approval, also debates continue in French courts over the legality of hemp flowers following the 2021 ban which was temporarily suspended. In France, oils & tinctures dominate the CBD product category due to their widespread availability and ease of consumption. Paris, Marseille, and Lyon are leading cities where consumers seek these products for their convenience and versatility, using them for daily wellness routines or as a natural remedy for anxiety and sleep issues. French pharmacies are also a key retail point for these oils, often marketed in different concentrations to suit varied needs.

Capsules & softgels have been growing in popularity across France, particularly among individuals in cities like Toulouse and Bordeaux, who prefer a precise dosage of CBD. These products are particularly appealing for people looking for a no-fuss, easy-to-integrate option into their wellness regimen. Gummies & confectionery products, such as CBD-infused gummy bears and chocolates, have found a niche in France, especially in Paris, where the younger, health-conscious population is more likely to experiment with edible CBD options. These products are sold in health food stores and specialty retailers, offering an enjoyable and discrete way of consuming cannabidiol. Topicals & skin care products are increasingly common, particularly in upscale beauty boutiques and pharmacies in cities like Nice and Lyon. These CBD-infused lotions, balms, and creams are marketed for their soothing properties, targeting consumers seeking relief from skin irritation or inflammation, with a growing focus on anti-aging benefits.

While vape products are available in major urban centers such as Paris and Marseille, their use is less widespread due to regulatory concerns around vaping. The others include less common formats such as CBD beverages, patches, or even bath products, available in specialized health stores or online platforms, offering French consumers a wide array of options for incorporating CBD into their lifestyles.The wellness & personal use category is the major segment for CBD products in France, particularly in major cities like Paris, Bordeaux, and Lyon, where residents increasingly view CBD as an essential part of their daily routine. French consumers commonly use CBD oils, tinctures, and capsules to manage stress, enhance sleep, and improve general well-being. The nutraceuticals & supplements market is also significant, especially in regions like Provence-Alpes-Côte d'Azur, where there is a strong emphasis on natural and holistic health practices. French consumers often integrate CBD into their supplement regimen alongside other vitamins and minerals for stress reduction and improved cognitive function. In the pet care market, the demand for CBD products is rising, particularly in cities like Toulouse and Paris, where pet owners are seeking out oils and treats to help alleviate their pets’ anxiety, pain, or mobility issues.

These products are increasingly available in veterinary clinics and pet stores across the country. The cosmetics & skin care sector has seen a surge in CBD-infused products, with cities like Paris, Cannes, and Nice driving demand for CBD creams, serums, and masks. These products are marketed for their anti-inflammatory and skin-soothing properties, gaining popularity among consumers looking for more natural beauty options. Pharmaceuticals is another growing end-use sector, as France continues to integrate medicinal cannabis and CBD products into its healthcare system. CBD is being explored for its therapeutic properties, particularly in treating conditions like epilepsy and chronic pain. Food & beverages represent an emerging segment, with CBD-infused drinks such as teas, coffees, and sparkling waters slowly becoming available in select cafés and health-focused stores in cities like Paris and Lyon, aligning with the country's growing trend toward functional beverages.In France, marijuana-derived CBD is still heavily regulated, and its legal use is mostly restricted to medicinal purposes.

Since the legalization of medical cannabis in 2021, marijuana-derived CBD products are being prescribed by doctors for patients suffering from conditions like epilepsy or chronic pain. These products are primarily available through licensed medical dispensaries and pharmacies in cities like Paris and Marseille. The French government’s cautious approach to marijuana cultivation and use means that marijuana-derived CBD remains a niche market for medical patients rather than general consumers. On the other hand, hemp-derived CBD dominates the broader French market, as France has a long history of cultivating hemp for industrial purposes. French hemp farms, especially in regions like Normandy and Aquitaine, are increasingly producing CBD from hemp strains that meet the legal limit for THC content, in line with EU regulations. Hemp-derived CBD is used in a wide range of products, from oils and tinctures to topicals, cosmetics, and edibles.

France’s agricultural infrastructure supports this hemp production, which is grown organically in many regions to meet the growing demand for CBD products. The hemp-derived CBD market is poised for expansion, particularly as consumers in France continue to embrace natural wellness products. Major French cities like Paris, Lyon, and Bordeaux have seen a surge in hemp-based CBD retailers, while the online market continues to grow, with many brands offering hemp-derived CBD products to a broad audience across the country. The legal framework surrounding hemp in France is relatively clear, making it easier for consumers to access a wide variety of hemp-derived CBD products that are sold both in-store and online.Considered in this report• Historic Year: 2019• Base year: 2024• Estimated year: 2025• Forecast year: 2030Aspects covered in this report• Cannabidiol Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Form• Oils & Tinctures• Capsules & Softgels• Gummies & Confectionery• Topicals / Skin Care• Vape Products• OthersBy End Use• Wellness & Personal Use• Nutraceuticals & Supplements• Pet Care• Cosmetics & Skin Care• Pharmaceuticals• Food & BeveragesBy Source• Marijuana• Hemp.